Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5756)
All Articles published online
|
May 14, 2010 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hung CH, Wang JH, Hu TH, Chen CH, Chang KC, Yen YH, Kuo YH, Tsai MC, Lu SN, Lee CM. Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection. World J Gastroenterol 2010; 16(18): 2265-2271 [PMID: 20458764 DOI: 10.3748/wjg.v16.i18.2265] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i18/2265.htm |
| Number | Citing Articles |
| 1 |
Ik-Rak Jung, Rexford S. Ahima, Sangwon F. Kim. Time-Restricted Feeding Ameliorates Methionine–Choline Deficient Diet-Induced Steatohepatitis in Mice. International Journal of Molecular Sciences 2024; 25(3): 1390 doi: 10.3390/ijms25031390
|
| 2 |
Guang-Ying Shi, Yu Sun, Xing-Chen Liang, Jing-Dong Xie. Clinical significance of expression of serum insulin-like growth factor-1 in patients with primary liver cancer and diabetes mellitus. World Chinese Journal of Digestology 2021; 29(5): 236 doi: 10.11569/wcjd.v29.i5.236
|
| 3 |
Menghan Zhang, Qi Wang, Gongming Zhang, Guangming Li, Ronghua Jin, Huichun Xing. A nomogram prognostic model for early hepatocellular carcinoma with diabetes mellitus after primary liver resection based on the admission characteristics. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1360478
|
| 4 |
Shintaro Kuroda, Hirotaka Tashiro, Tsuyoshi Kobayashi, Akihiko Oshita, Hironobu Amano, Hideki Ohdan. Selection Criteria for Hepatectomy in Patients with Hepatocellular Carcinoma Classified as Child‐Pugh Class B. World Journal of Surgery 2011; 35(4): 834 doi: 10.1007/s00268-010-0929-y
|
| 5 |
Toru Arano, Hayato Nakagawa, Ryosuke Tateishi, Hitoshi Ikeda, Koji Uchino, Kenichiro Enooku, Eriko Goto, Ryota Masuzaki, Yoshinari Asaoka, Yuji Kondo, Tadashi Goto, Shuichiro Shiina, Masao Omata, Haruhiko Yoshida, Kazuhiko Koike. Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients. International Journal of Cancer 2011; 129(9): 2226 doi: 10.1002/ijc.25861
|
| 6 |
Takumi Kawaguchi, Eitaro Taniguchi, Minoru Itou, Masahiro Sakata, Shuji Sumie, Michio Sata. Insulin resistance and chronic liver disease. World Journal of Hepatology 2011; 3(5): 99-107 doi: 10.4254/wjh.v3.i5.99
|
| 7 |
Anne‐Aurélie Raymond, Joaquim Javary, Osman Breig, Véronique Neaud, Jean Rosenbaum. Reptin regulates insulin‐stimulated Akt phosphorylation in hepatocellular carcinoma via the regulation of SHP‐1/PTPN6. Cell Biochemistry and Function 2017; 35(6): 289 doi: 10.1002/cbf.3274
|
| 8 |
Chao-Hung Hung, Chuan-Mo Lee, Sheng-Nan Lu. Hepatitis C virus-associated insulin resistance: pathogenic mechanisms and clinical implications. Expert Review of Anti-infective Therapy 2011; 9(5): 525 doi: 10.1586/eri.11.33
|
| 9 |
Tawhida Y Abdel-Ghaffar, Mostafa M Sira, Suzan El Naghi. Hepatitis C genotype 4: The past, present, and future. World Journal of Hepatology 2015; 7(28): 2792-2810 doi: 10.4254/wjh.v7.i28.2792
|
| 10 |
Mary-Anne Doyle, Chrissi Galanakis, Erin Mulvihill, Angela Crawley, Curtis L. Cooper. Hepatitis C Direct Acting Antivirals and Ribavirin Modify Lipid but not Glucose Parameters. Cells 2019; 8(3): 252 doi: 10.3390/cells8030252
|
| 11 |
M. Eslam, T. Kawaguchi, J. A. Del Campo, M. Sata, M. Abo-Elneen Khattab, M. Romero-Gomez. Use of HOMA-IR in hepatitis C. Journal of Viral Hepatitis 2011; 18(10): 675 doi: 10.1111/j.1365-2893.2011.01474.x
|
| 12 |
Mohamed Hassan, Denis Selimovic, Abdelouahid El-Khattouti, Hanan Ghozlan, Youssef Haikel, Ola Abdelkader. Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies. World Journal of Experimental Medicine 2012; 2(2): 7-25 doi: 10.5493/wjem.v2.i2.7
|
| 13 |
Violeta B. Popov, Joseph K. Lim. Impact of Insulin-Sensitizing Agents on Risk for Liver Cancer and Liver-Related Death in Diabetic Patients with Compensated Hepatitis C Cirrhosis. The Journal of Clinical Endocrinology & Metabolism 2011; 96(8): 2398 doi: 10.1210/jc.2011-1875
|
| 14 |
Jing-Houng Wang, Wei-Feng Li, Chee-Chien Yong, Yueh-Wei Liu, Sheng-Nan Lu, Chih-Chi Wang. Liver stiffness and insulin resistance in predicting recurrence for early stage hepatoma patients after curative resection. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-85431-y
|
| 15 |
Yinshuang Chen, Weipeng Wang, Maria P. Morgan, Tracy Robson, Stephanie Annett. Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1148934
|
| 16 |
Chun‐Hsun Yang, Yi‐Chun Chiu, Chih‐Hung Chen, Chien‐Hung Chen, Ming‐Chao Tsai, Seng‐Kee Chuah, Chih‐Hsiung Lee, Tsung‐Hui Hu, Chao‐Hung Hung. Diabetes mellitus is associated with gastroesophageal variceal bleeding in cirrhotic patients. The Kaohsiung Journal of Medical Sciences 2014; 30(10): 515 doi: 10.1016/j.kjms.2014.06.002
|
| 17 |
Livia M Villar, Cristiane A Villela-Nogueira, Allan P da Silva, Letícia P Scalioni. Hepatitis C - From Infection to Cure. 2018; doi: 10.5772/intechopen.77387
|
| 18 |
Naoki Yoshida, Yutaka Midorikawa, Tokio Higaki, Hisashi Nakayama, Shingo Tsuji, Shunichi Matsuoka, Hisamitsu Ishihara, Mitsuhiko Moriyama, Tadatoshi Takayama. Diabetes mellitus not an unfavorable factor on the prognosis of hepatitis C virus‐related hepatocellular carcinoma. Hepatology Research 2018; 48(1): 28 doi: 10.1111/hepr.12888
|
| 19 |
Mary-Anne Doyle, Joel Singer, Terry Lee, Miriam Muir, Curtis Cooper. Improving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trial. Trials 2016; 17(1) doi: 10.1186/s13063-016-1454-6
|
| 20 |
Inas El Khedr Mohamed, Hany Samir Rasmy, Wagih Abd Elwahab Aly. Evaluation of serum resistin levels in patients with hepatocellular carcinoma before and after treatment. Egyptian Liver Journal 2018; 8(2): 61 doi: 10.1097/01.ELX.0000546516.15821.c2
|
| 21 |
Sherif Mogawer, Mona Mansour, Mohamed Marie, Mervat El-Ansary, Samah Abd El-Hamid. Insulin resistance: a predictor for response to interferon-based therapy in Egyptian patients with chronic HCV genotype 4. Comparative Clinical Pathology 2014; 23(1): 7 doi: 10.1007/s00580-012-1560-0
|
| 22 |
Loraine Kay D. Cabral, Luca Grisetti, Muhammad Yogi Pratama, Claudio Tiribelli, Devis Pascut. Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals. Cancers 2022; 14(11): 2700 doi: 10.3390/cancers14112700
|
| 23 |
Anne-Claire Desbois, Patrice Cacoub. Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review. World Journal of Gastroenterology 2017; 23(9): 1697-1711 doi: 10.3748/wjg.v23.i9.1697
|
| 24 |
Letiția Adela Maria Streba, Cristin Constantin Vere, Ion Rogoveanu, Costin Teodor Streba. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: An open question. World Journal of Gastroenterology 2015; 21(14): 4103-4110 doi: 10.3748/wjg.v21.i14.4103
|
| 25 |
Sooyeon Oh, Jooho Lee. Sarcopenia and blood myokine levels as prognostic biomarkers in patients with liver cirrhosis or hepatocellular carcinoma. Clinical and Molecular Hepatology 2020; 26(4): 476 doi: 10.3350/cmh.2020.0192
|
| 26 |
Marie Sinclair, Mathis Grossmann, Peter W Angus, Rudolf Hoermann, Penelope Hey, Thomas Scodellaro, Paul J Gow. Low testosterone as a better predictor of mortality than sarcopenia in men with advanced liver disease. Journal of Gastroenterology and Hepatology 2016; 31(3): 661 doi: 10.1111/jgh.13182
|
| 27 |
Ganji Purnachandra Nagaraju, Sheik Aliya, Olatunji Boladale Alese. Role of adiponectin in obesity related gastrointestinal carcinogenesis. Cytokine & Growth Factor Reviews 2015; 26(1): 83 doi: 10.1016/j.cytogfr.2014.06.007
|
| 28 |
K. Hamdy, R. Al Swaff, H. A. Hussein, M. Gamal. Assessment of serum adiponectin in Egyptian patients with HCV-related cirrhosis and hepatocellular carcinoma. Journal of Endocrinological Investigation 2015; 38(11): 1225 doi: 10.1007/s40618-015-0379-3
|
| 29 |
Andra-Iulia Suceveanu, Laura Mazilu, Andreea-Daniela Gheorghe, Anca Pantea Stoian, Felix Voinea, Adrian-Paul Suceveanu. Liver Cancer. 2018; doi: 10.5772/intechopen.80527
|
| 30 |
Mohamed Magdy Salama, Walaa Ahmed Kabiel, Silvia Shoukry Hana, Ghada Abdelrahman Mohamed. Correlation of serum betatrophin levels with disease severity and the emergence of insulin resistance in cirrhotic patients. Egyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-00039-7
|
| 31 |
F. Gelley, G. Zadori, G. Firneisz, L. Wagner, I. Fehervári, Z. Gerlei, J. Fazakas, S. Papai, G. Lengyel, E. Sarvary, B. Nemes. Relationship Between Hepatitis C Virus Recurrence and De Novo Diabetes After Liver Transplantation: The Hungarian Experience. Transplantation Proceedings 2011; 43(4): 1281 doi: 10.1016/j.transproceed.2011.03.065
|
| 32 |
Marie Sinclair, Mathis Grossmann, Paul J Gow, Peter W Angus. Testosterone in men with advanced liver disease: Abnormalities and implications. Journal of Gastroenterology and Hepatology 2015; 30(2): 244 doi: 10.1111/jgh.12695
|
| 33 |
Fumiaki Konishi, Teruki Miyake, Takao Watanabe, Yoshio Tokumoto, Shinya Furukawa, Bunzo Matsuura, Osamu Yoshida, Masumi Miyazaki, Akihito Shiomi, Sayaka Kanzaki, Hironobu Nakaguchi, Yoshiko Nakamura, Yusuke Imai, Mitsuhito Koizumi, Yasunori Yamamoto, Yohei Koizumi, Masashi Hirooka, Eiji Takeshita, Teru Kumagi, Yoshio Ikeda, Masanori Abe, Yoichi Hiasa. Association of abnormal glucose tolerance with liver‐related disease and cardiovascular diseases in patients with chronic hepatitis C. Hepatology Research 2023; 53(9): 806 doi: 10.1111/hepr.13925
|
| 34 |
Herbert Tilg, Alexander R. Moschen. Mechanisms behind the link between obesity and gastrointestinal cancers. Best Practice & Research Clinical Gastroenterology 2014; 28(4): 599 doi: 10.1016/j.bpg.2014.07.006
|
| 35 |
Amedeo Lonardo, Stefano Ballestri, Giovanni Guaraldi, Fabio Nascimbeni, Dante Romagnoli, Stefano Zona, Giovanni Targher. Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV. World Journal of Gastroenterology 2016; 22(44): 9674-9693 doi: 10.3748/wjg.v22.i44.9674
|
| 36 |
Marin E. Healy, Sujoy Lahiri, Stefan R. Hargett, Jenny D.Y. Chow, Frances L. Byrne, David S. Breen, Brandon M. Kenwood, Evan P. Taddeo, Carolin Lackner, Stephen H. Caldwell, Kyle L. Hoehn. Dietary sugar intake increases liver tumor incidence in female mice. Scientific Reports 2016; 6(1) doi: 10.1038/srep22292
|
| 37 |
Jack Leslie, Daniel Geh, Ahmed M. Elsharkawy, Derek A. Mann, Michele Vacca. Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions. Journal of Hepatology 2022; 77(1): 219 doi: 10.1016/j.jhep.2022.01.029
|
| 38 |
Maria Corina Plaz Torres, Ariel Jaffe, Rachel Perry, Elisa Marabotto, Mario Strazzabosco, Edoardo G. Giannini. Diabetes medications and risk of HCC. Hepatology 2022; 76(6): 1880 doi: 10.1002/hep.32439
|
| 39 |
Shinji Iwane, Toshihiko Mizuta, Yasunori Kawaguchi, Hirokazu Takahashi, Noriko Oza, Satoshi Oeda, Shunya Nakashita, Takuya Kuwashiro, Taiga Otsuka, Seiji Kawazoe, Yuichiro Eguchi, Keizo Anzai, Iwata Ozaki, Kazuma Fujimoto. Impact of Body Weight Reduction via Diet and Exercise on the Anti-Viral Effects of Pegylated Interferon Plus Ribavirin in Chronic Hepatitis C Patients with Insulin Resistance: A Randomized Controlled Pilot Trial. Internal Medicine 2015; 54(24): 3113 doi: 10.2169/internalmedicine.54.5574
|
| 40 |
Takashi Himoto, Takako Nomura, Joji Tani, Hisaaki Miyoshi, Asahiro Morishita, Hirohito Yoneyama, Reiji Haba, Hisashi Masugata, Tsutomu Masaki. Exacerbation of Insulin Resistance and Hepatic Steatosis Deriving from Zinc Deficiency in Patients with HCV-Related Chronic Liver Disease. Biological Trace Element Research 2015; 163(1-2): 81 doi: 10.1007/s12011-014-0177-3
|
| 41 |
Yusuf Yilmaz, Yasar Colak, Ramazan Kurt, Ebubekir Senates, Fatih Eren. Linking Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: From Bedside to Bench and Back. Tumori Journal 2013; 99(1): 10 doi: 10.1177/030089161309900102
|
| 42 |
Yoshinao Kobayashi, Motoh Iwasa, Hirohide Miyachi, Ryosuke Sugimoto, Hideaki Tanaka, Rumi Mifuji-Moroka, Naoki Fujita, Yasuhiro Sumida, Yoshiyuki Takei. Effect of Iron-Mediated Oxidative Stress on Insulin Resistance Through the Forkhead Box-Containing Protein O Subfamily-1 (FOXO-1) Pathway in Chronic Hepatitis C. International Journal of Clinical Medicine 2013; 4(01): 10 doi: 10.4236/ijcm.2013.41004
|
| 43 |
Wei-feng Shan, Bing-quan Chen, Shao-jun Zhu, Li Jiang, Yan-feng Zhou. Effects of GLUT4 expression on insulin resistance in patients with advanced liver cirrhosis. Journal of Zhejiang University SCIENCE B 2011; 12(8): 677 doi: 10.1631/jzus.B1100001
|
| 44 |
Marie Sinclair, Paul J. Gow, Mathis Grossmann, Adam Shannon, Rudolf Hoermann, Peter W. Angus. Low serum testosterone is associated with adverse outcome in men with cirrhosis independent of the model for end‐stage liver disease score. Liver Transplantation 2016; 22(11): 1482 doi: 10.1002/lt.24607
|
| 45 |
Mary-Anne Doyle, Terry Lee, Joel Singer, Angela Crawley, Marina Klein, Curtis Cooper. Evaluation of Safety and Effectiveness of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Switch Followed by Ledipasvir/Sofosbuvir HCV Therapy in HIV–HCV Coinfection. Open Forum Infectious Diseases 2019; 6(7) doi: 10.1093/ofid/ofz318
|
| 46 |
Kazuhisa Kaneda, Takahiro Uenishi, Shigekazu Takemura, Hiroji Shinkawa, Yorihisa Urata, Masayuki Sakae, Takatsugu Yamamoto, Shoji Kubo. The influence of postoperative glycemic control on recurrence after curative resection in diabetics with hepatitis C virus‐related hepatocellular carcinoma. Journal of Surgical Oncology 2012; 105(6): 606 doi: 10.1002/jso.22137
|
| 47 |
Dominique Salmon, Firouzé Bani-Sadr, Marc-Arthur Loko, Hind Stitou, Anne Gervais, Jacques Durant, Eric Rosenthal, Yann Quertainmont, Karl Barange, Daniel Vittecoq, Michka Shoai-Tehrani, Muriel Alvarez, Maria Winnock, Jean Claude Trinchet, François Dabis, Philippe Sogni. Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: Results from ANRS CO13 HEPAVIH. Journal of Hepatology 2012; 56(4): 862 doi: 10.1016/j.jhep.2011.11.009
|
| 48 |
ALDONA KASPRZAK, AGNIESZKA ADAMEK. The insulin-like growth factor (IGF) signaling axis and hepatitis C virus-associated carcinogenesis (Review). International Journal of Oncology 2012; 41(6): 1919 doi: 10.3892/ijo.2012.1666
|
| 49 |
Chung-Feng Huang, Ming-Lun Yeh, Cing-Yi Huang, Pei-Chien Tsai, Yu-Min Ko, Kuan-Yu Chen, Zu-Yau Lin, Shinn-Cherng Chen, Chia-Yen Dai, Wan-Long Chuang, Jee-Fu Huang, Ming-Lung Yu. Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapy. Medicine 2016; 95(27): e4157 doi: 10.1097/MD.0000000000004157
|
| 50 |
Amal A Mohamed, Samah A Loutfy, James D Craik, Abdel Gawad M Hashem, Ibrahem Siam. Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma. Virology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-496
|
| 51 |
Zeynel Abidin Ozturk, Abdurrahman Kadayifci. Insulin sensitizers for the treatment of non-alcoholic fatty liver disease. World Journal of Hepatology 2014; 6(4): 199-206 doi: 10.4254/wjh.v6.i4.199
|
| 52 |
Beatriz Mateos-Muñoz, Elena García-Martín, María J. Torrejón, María J. Devesa-Medina, Gara Esguevillas, María C. Cárdenas, Cristina Fernández, Miguel Carballo, José A. Agúndez, José M. Ladero. GC Gene Polymorphism and Unbound Serum Retinol-Binding Protein 4 Are Related to the Risk of Insulin Resistance in Patients With Chronic Hepatitis C. Medicine 2016; 95(10): e3019 doi: 10.1097/MD.0000000000003019
|
| 53 |
Pierre Deltenre, Alexandre Louvet, Maud Lemoine, Abbas Mourad, Laetitia Fartoux, Christophe Moreno, Jean Henrion, Philippe Mathurin, Lawrence Serfaty. Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: A meta-analysis. Journal of Hepatology 2011; 55(6): 1187 doi: 10.1016/j.jhep.2011.03.010
|
| 54 |
Toru Arano, Hayato Nakagawa, Hitoshi Ikeda, Kazuhiko Koike. Adiponectin in chronic hepatitis C. Clinical Journal of Gastroenterology 2013; 6(4): 259 doi: 10.1007/s12328-013-0410-1
|
| 55 |
A. A. Butt, T. Umbleja, J. W. Andersen, K. E. Sherman, R. T. Chung. Impact of Peginterferon Alpha and Ribavirin Treatment on Lipid Profiles and Insulin Resistance in Hepatitis C Virus/HIV-Coinfected Persons: The AIDS Clinical Trials Group A5178 Study. Clinical Infectious Diseases 2012; 55(5): 631 doi: 10.1093/cid/cis463
|
| 56 |
Omar T. Sims, David E. Pollio, Barry A. Hong, Carol S. North. Racial Disparities in Hepatitis C Treatment Eligibility. Annals of Hepatology 2017; 16(4): 530 doi: 10.5604/01.3001.0010.0282
|
| 57 |
Mariana Lazo, Chizoba Nwankwo, Natalie R. Daya, David L. Thomas, Shruti H. Mehta, Stephen Juraschek, Kerry Willis, Elizabeth Selvin. Confluence of Epidemics of Hepatitis C, Diabetes, Obesity, and Chronic Kidney Disease in the United States Population. Clinical Gastroenterology and Hepatology 2017; 15(12): 1957 doi: 10.1016/j.cgh.2017.04.046
|
| 58 |
Sayoko Sumiyoshi, Terumi Takahara, Kazuto Shibuya, Johji Imura, Akira Noguchi, Kazuto Tajiri, Masami Minemura, Tsutomu Fujii, Kenichi Hirabayashi. Hepatocellular carcinoma in a transplanted donor liver and colon cancer developing in a patient with a complex background: A case report. Oncology Letters 2024; 27(4) doi: 10.3892/ol.2024.14301
|
| 59 |
Takashi Himoto, Joji Tani, Hisaaki Miyoshi, Asahiro Morishita, Hirohito Yoneyama, Kazutaka Kurokohchi, Michio Inukai, Hisashi Masugata, Fuminori Goda, Shoichi Senda, Reiji Haba, Masaki Ueno, Genji Yamaoka, Tsutomu Masaki. Investigation of the factors associated with circulating soluble CD36 levels in patients with HCV-related chronic liver disease. Diabetology & Metabolic Syndrome 2013; 5(1) doi: 10.1186/1758-5996-5-51
|
| 60 |
Seyyed Mortaza Haghgoo, Heidar Sharafi, Seyed Moayed Alavian. Serum cytokines, adipokines and ferritin for non-invasive assessment of liver fibrosis in chronic liver disease: a systematic review. Clinical Chemistry and Laboratory Medicine (CCLM) 2019; 57(5): 577 doi: 10.1515/cclm-2018-0357
|
| 61 |
Takumi Kawaguchi, Dan Nakano, Takuji Torimura. Alcoholic/Non-Alcoholic Digestive Diseases. 2019; : 65 doi: 10.1007/978-981-13-1465-0_7
|
| 62 |
Tzu-Min Hung, Cheng-Maw Ho, Yen-Chun Liu, Jia-Ling Lee, Yow-Rong Liao, Yao-Ming Wu, Ming-Chih Ho, Chien-Hung Chen, Hong-Shiee Lai, Po-Huang Lee, Dong-Yan Jin. Up-Regulation of MicroRNA-190b Plays a Role for Decreased IGF-1 That Induces Insulin Resistance in Human Hepatocellular Carcinoma. PLoS ONE 2014; 9(2): e89446 doi: 10.1371/journal.pone.0089446
|
| 63 |
Blake A. Niccum, Jonathan G. Stine, Javelle A. Wynter, Virginia Kelly, Stephen H. Caldwell, Neeral L. Shah. Success of Direct-Acting, Antiviral-Based Therapy for Chronic Hepatitis C Is Not Affected by Type 2 Diabetes. Clinical Diabetes 2020; 38(1): 40 doi: 10.2337/cd18-0112
|
| 64 |
C. Desbois-Mouthon. De la stéatohépatite non alcoolique au carcinome hépatocellulaire : mécanismes physiopathologiques. Médecine des Maladies Métaboliques 2011; 5(1): 38 doi: 10.1016/S1957-2557(11)70184-5
|
| 65 |
Marie Sinclair, Mathis Grossmann, Rudolf Hoermann, Peter W. Angus, Paul J. Gow. Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: A randomised controlled trial. Journal of Hepatology 2016; 65(5): 906 doi: 10.1016/j.jhep.2016.06.007
|
| 66 |
Zhitao Chen, Chenchen Ding, Kailei Chen, Yangjun Gu, Xiaoxia Qiu, Qiyong Li. Investigating the causal association between obesity and risk of hepatocellular carcinoma and underlying mechanisms. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-66414-1
|
| 67 |
Yuko Nagaoki, Hideyuki Hyogo, Yuwa Ando, Yumi Kosaka, Shinsuke Uchikawa, Yuno Nishida, Yuji Teraoka, Kei Morio, Hatsue Fujino, Atsushi Ono, Takashi Nakahara, Eisuke Murakami, Masami Yamauchi, Wataru Okamoto, Tomokazu Kawaoka, Masataka Tsuge, Akira Hiramatsu, Daiki Miki, Michio Imamura, Shoichi Takahashi, Kazuaki Chayama, Hiroshi Aikata. Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year study. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01884-5
|
| 68 |
Arup Banerjee, Ratna B. Ray, Ranjit Ray. Oncogenic Potential of Hepatitis C Virus Proteins. Viruses 2010; 2(9): 2108 doi: 10.3390/v2092108
|
| 69 |
Carmela Loguercio, Pietro Andreone, Ciprian Brisc, Michaela Cristina Brisc, Elisabetta Bugianesi, Maria Chiaramonte, Carmela Cursaro, Mirela Danila, Ilario de Sio, Annarosa Floreani, Maria Antonietta Freni, Antonio Grieco, Marzia Groppo, Roberta Lazzari, Salvatore Lobello, Elisabetta Lorefice, Marzia Margotti, Luca Miele, Stefano Milani, Lajos Okolicsanyi, Giuseppe Palasciano, Piero Portincasa, Patrizia Saltarelli, Antonina Smedile, Francesco Somalvico, Aldo Spadaro, Ioan Sporea, Paolo Sorrentino, Raffaela Vecchione, Concetta Tuccillo, Camillo Del Vecchio Blanco, Alessandro Federico. Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial. Free Radical Biology and Medicine 2012; 52(9): 1658 doi: 10.1016/j.freeradbiomed.2012.02.008
|
| 70 |
Takashi Oono, Takahiro Yamasaki, Junichi Zaitsu, Issei Saeki, Takuya Iwamoto, Yumiko Harima, Yoshio Marumoto, Isao Hidaka, Yohei Urata, Tsuyoshi Ishikawa, Taro Takami, Makoto Segawa, Koichi Uchida, Shuji Terai, Ichiro Kunitugu, Tsuyoshi Tanabe, Isao Sakaida. Association of tyrosine with insulin resistance in hepatitis C virus‐related chronic liver disease. Hepatology Research 2014; 44(10) doi: 10.1111/hepr.12213
|
| 71 |
M. Sinclair, P. J. Gow, M. Grossmann, P. W. Angus. Review article: sarcopenia in cirrhosis – aetiology, implications and potential therapeutic interventions. Alimentary Pharmacology & Therapeutics 2016; 43(7): 765 doi: 10.1111/apt.13549
|
| 72 |
Emanuele Rinninella, Lucia Cerrito, Irene Spinelli, Marco Cintoni, Maria Cristina Mele, Maurizio Pompili, Antonio Gasbarrini. Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives. Journal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2017.00002
|
| 73 |
Carolina M. Pusec, Vladimir Ilievski, Adam De Jesus, Zeenat Farooq, Joseph L. Zapater, Nadia Sweis, Hagar Ismail, Md Wasim Khan, Hossein Ardehali, Jose Cordoba-Chacon, Brian T. Layden. Liver-specific overexpression of HKDC1 increases hepatocyte size and proliferative capacity. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-33924-3
|
| 74 |
Areeba Rehman, Maria Shabbir, Yasmin Badshah, Khushbukhat Khan, Janeen H. Trembley, Naeem Mahmood Ashraf, Tayyaba Afsar, Ali Almajwal, Nawaf W. Alruwaili, Ali Alshamari, Tariq Nahar Alanezi, Suhail Razak. Elucidating the role of missense SNP of protein kinase C epsilon in HCV-induced hepatocellular carcinoma. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10618-7
|
| 75 |
Nicolas Goossens, Sophie Clément, Francesco Negro. Handbook of Hepatitis C. 2016; : 33 doi: 10.1007/978-3-319-28053-0_4
|
| 76 |
Anil C. Anand. Nutrition and Muscle in Cirrhosis. Journal of Clinical and Experimental Hepatology 2017; 7(4): 340 doi: 10.1016/j.jceh.2017.11.001
|
| 77 |
Vincenzo Boccaccio, Savino Bruno. Optimal management of patients with chronic hepatitis C and comorbidities. Liver International 2015; 35(s1): 35 doi: 10.1111/liv.12712
|
| 78 |
Jinyan Zhao, Yunpeng Zhao, Hao Wang, Xing Gu, Jun Ji, Chunfang Gao. Association between metabolic abnormalities and HBV related hepatocelluar carcinoma in Chinese: A cross-sectional study. Nutrition Journal 2011; 10(1) doi: 10.1186/1475-2891-10-49
|
| 79 |
Hamza Chettouh, Marie Lequoy, Laetitia Fartoux, Corinne Vigouroux, Christèle Desbois‐Mouthon. Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma. Liver International 2015; 35(10): 2203 doi: 10.1111/liv.12903
|
| 80 |
Mary-Anne Doyle, Curtis Cooper. Successful Hepatitis C Antiviral Therapy Induces Remission of Type 2 Diabetes: A Case Report. American Journal of Case Reports 2015; 16: 745 doi: 10.12659/AJCR.895064
|
| 81 |
Engy Yousry Elsayed, Nesreen Ahmed Mosalam, Noha Refaat Mohamed. Resistin and Insulin Resistance: A Link Between Inflammation and Hepatocarcinogenesis. Asian Pacific Journal of Cancer Prevention 2015; 16(16): 7139 doi: 10.7314/APJCP.2015.16.16.7139
|
| 82 |
Krasimira Aleksandrova, Heiner Boeing, Ute Nöthlings, Mazda Jenab, Veronika Fedirko, Rudolf Kaaks, Annekatrin Lukanova, Antonia Trichopoulou, Dimitrios Trichopoulos, Paolo Boffetta, Elisabeth Trepo, Sabine Westhpal, Talita Duarte-Salles, Magdalena Stepien, Kim Overvad, Anne Tjφnneland, Jytte Halkjær, Marie-Christine Boutron-Ruault, Laure Dossus, Antoine Racine, Pagona Lagiou, Christina Bamia, Vassiliki Benetou, Claudia Agnoli, Domenico Palli, Salvatore Panico, Rosario Tumino, Paolo Vineis, Bas Bueno-de-Mesquita, Petra H. Peeters, Inger Torhild Gram, Eiliv Lund, Elisabete Weiderpass, Ramón J. Quirós, Antonio Agudo, María-José Sánchez, Diana Gavrila, Aurelio Barricarte, Miren Dorronsoro, Bodil Ohlsson, Björn Lindkvist, Anders Johansson, Malin Sund, Kay-Tee Khaw, Nicholas Wareham, Ruth C. Travis, Elio Riboli, Tobias Pischon. Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer. Hepatology 2014; 60(3): 858 doi: 10.1002/hep.27016
|
| 83 |
Jung Hee Kim, Dong Hyun Sinn, Geum‐Youn Gwak, Wonseok Kang, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik. Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patients. Journal of Gastroenterology and Hepatology 2017; 32(5): 1100 doi: 10.1111/jgh.13647
|
| 84 |
Ammar Hassan, Elliot B. Tapper. The Critically Ill Cirrhotic Patient. 2020; : 141 doi: 10.1007/978-3-030-24490-3_9
|
| 85 |
Cheng-Hao Su, Yong Lin, Lin Cai. Genetic Factors, Viral Infection, Other Factors and Liver Cancer: An Update on Current Progress. Asian Pacific Journal of Cancer Prevention 2013; 14(9): 4953 doi: 10.7314/APJCP.2013.14.9.4953
|
| 86 |
Iva Košuta, Anna Mrzljak, Branko Kolarić, Marijana Vučić Lovrenčić. Leptin as a Key Player in Insulin Resistance of Liver Cirrhosis? A Cross-Sectional Study in Liver Transplant Candidates. Journal of Clinical Medicine 2020; 9(2): 560 doi: 10.3390/jcm9020560
|